The Basics
- Eugeroic (wakefulness-promoting) research compound
- Bisfluoro analog of adrafinil / modafinil family
- Typical onset 30–60 min · effects ~6–8 hours
- Available as 20 mg capsules or powder
N
Skip to contentOn-demand alertness and mental drive for long study or work days—clearly dosed Fladrafinil (capsules & powder), delivered fast from Dubai.
Stimulating and experimental. Dose in the morning only, never daily. Not for use if pregnant, nursing, or on medication. See our safety guide.
Fladrafinil is a eugeroic (wakefulness-promoting) research compound in the adrafinil/modafinil family.
Dose once in the morning (before 10am); effects last roughly 6–8 hours.
Limit to 2–4× per week to manage tolerance and protect sleep.
Available as convenient 20 mg capsules and powder for advanced users.
Experimental compound with limited human data—use conservatively and responsibly.
Fladrafinil (CRL-40,941) is a eugeroic, or wakefulness-promoting, research compound. It is the bisfluoro structural analog of adrafinil, which is itself a prodrug of modafinil. People reach for it to support sustained alertness and focus during demanding days, without the jittery overstimulation of high-dose caffeine.
Class: eugeroic; part of the adrafinil/modafinil family developed at Lafon Laboratories. Fladrafinil is thought to influence dopamine and orexin signaling, systems tied to wakefulness and motivation. Onset is typically 30–60 minutes with effects lasting roughly 6–8 hours; timing and response vary by individual and dose.
Fladrafinil is an unapproved research compound with very limited human data. Informational only. Not medical advice.
This content is educational and not medical advice. Fladrafinil is an experimental research compound for adult use only. Dose in the morning, never daily. Do not combine with other stimulants.
Where Fladrafinil can help—when used occasionally and dosed in the morning.
Steady daytime alertness without the jittery spikes of harsh stimulants.
As a eugeroic, Fladrafinil is used to extend wakefulness during long days. Dose in the morning only; effects can last 6–8 hours. Avoid late-day use to protect sleep.
Helps sustain attention through long study or work sessions.
Users report smoother, more sustained focus for demanding tasks. Start with a single 20 mg capsule to assess your response before adjusting.
Supports mental drive when you need to push through demanding output.
By modulating wakefulness-related signaling, it can help maintain drive across a long block of work. More is not better—keep to conservative dosing.
Takes the edge off tiredness so focus feels more even late in the day.
A steadier wakefulness baseline can make long sessions feel less draining. If you feel overstimulated, you likely took too much—reduce frequency and dose.
This content is educational, not medical advice. Use Fladrafinil occasionally, in the morning. Do not combine with other stimulants.
Fladrafinil is a eugeroic thought to act on dopamine and orexin signaling, systems that regulate wakefulness and motivation.
As the bisfluoro analog of adrafinil, Fladrafinil sits in the modafinil family of wakefulness-promoting compounds. It aims to extend alertness and focus while avoiding the jittery peaks typical of caffeine. Effects vary by dose, form, and individual.
| Form | Solubility | Typical Dose | Onset | Notes |
|---|---|---|---|---|
| Capsules (20 mg) | N/A | 20 mg (1 capsule) | 30–60 min | Pre-measured and most convenient. Dose in the morning. |
| Powder | Fat-soluble | Weigh precisely | 30–60 min | For advanced users. A milligram scale is essential. |
Informational only. Not medical advice.
Use Fladrafinil occasionally and in the morning. Start low. Do not combine with other stimulants.
| Form | Dose Range | Frequency | Onset/Duration |
|---|---|---|---|
| Capsules (20 mg) | 20 mg | 2–4×/week | AM only, before 10am |
| Powder | Weigh; follow label | 2–4×/week | AM only |
Educational only. Not medical advice. Fladrafinil is an unapproved research compound.
How Fladrafinil compares to gentler focus options you might try first.
| Option | Mechanism | Best For | Onset | Notes |
|---|---|---|---|---|
| Fladrafinil | Eugeroic; adrafinil analog promoting wakefulness | Long, demanding days without classic stimulant edge | 30–60 min | The compound this guide covers — smooth, extended wakefulness. |
| Caffeine + L-Theanine | Adenosine block + alpha waves | Everyday smooth focus | 15–30 min | Gentle daily option; pairs calm with energy. |
| Phenylpiracetam Hydrazide | Racetam-class stimulation | High-output crunch days | 40 min | Stronger push; pair with a choline donor. |
| Alpha-GPC | Choline donor | Memory & deep work | 30 min | Non-stimulant; supports acetylcholine. |
Fladrafinil belongs to the eugeroic family developed alongside adrafinil and modafinil. Human data on Fladrafinil specifically is very limited, so it should be considered experimental and dosed conservatively.
Educational only; not medical advice.
Capsules and powder—clearly dosed, lab-tested, and shipped fast from Dubai.
Fladrafinil is in the same eugeroic family. Many users report a quicker onset (~30 minutes) and a shorter duration (6–8 hours) with smoother effects. It is a research compound, not a medicine.
Yes, if taken late. Always dose in the morning to protect sleep quality.
No—limit use to 2–4 times per week to manage tolerance.
No. Fladrafinil is an unapproved research compound with very limited human data. Its use is experimental and it is not intended to diagnose, treat, cure, or prevent any disease.
Adult students, professionals, and experienced nootropic users who want clean, occasional wakefulness support for demanding days.
Lab-tested quality • 4-hour delivery in Dubai • Express worldwide • Free express shipping 300 AED+
Ships today from Dubai — order by 6pm